Assessment of the Anticancer Effect of Chlorojanerin Isolated from Centaurothamnus maximus on A549 Lung Cancer Cells
Molecules · 2023
DOI: 10.3390/molecules28073061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Omar Noman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Biology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, Germany. Hauptthemen laut MEDLINE: Lung Neoplasms. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University.
Abstract (Originalsprache)
The goal of this study was to assess the anticancer efficacy of chlorojanerin against various cancer cells. The effects of chlorojanerin on cell cytotoxicity, cell cycle arrest, and cell apoptosis were examined using MTT assay, propidium iodide staining, and FITC Annexin V assay. RT-PCR was employed to determine the expression levels of apoptosis-related genes. Furthermore, docking simulations were utilized to further elucidate the binding preferences of chlorojanerin with Bcl-2. According to MTT assay, chlorojanerin inhibited the proliferation of all tested cells in a dose-dependent manner with a promising effect against A549 lung cancer cells with an IC50 of 10 µM. Cell growth inhibition by chlorojanerin was linked with G2/M phase cell cycle arrest in A549 treated cells. Flow cytometry analysis indicated that the proliferation inhibition effect of chlorojanerin was associated with apoptosis induction in A549 cells. Remarkably, chlorojanerin altered the expression of many genes involved in apoptosis initiation. Moreover, we determined that chlorojanerin fit into the active site of Bcl-2 according to the molecular docking study. Collectively, our results demonstrate that chlorojanerin mediated an anticancer effect involving cell cycle arrest and apoptotic cell death and, therefore, could potentially serve as a therapeutic agent in lung cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Biology, Institute of Pharmacy, University of Greifswald, 17489 Greifswald, Germany.
- Department of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
- Department of Pharmacology and Toxicology, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.
ORCID-Profile: Fahd A Nasr, Md Tabish Rehman, Wajhul Qamar, Ali S Alqahtani
Förderung
- King Saud University
Zitieren
APA
Noman, O., Nasr, F. A., Ahmed, M. Z., Rehman, M. T., Qamar, W., Alqahtani, A. S., & Guenther, S. (2023). Assessment of the Anticancer Effect of Chlorojanerin Isolated from Centaurothamnus maximus on A549 Lung Cancer Cells. Molecules. https://doi.org/10.3390/molecules28073061
Vancouver
Noman O, Nasr FA, Ahmed MZ, Rehman MT, Qamar W, Alqahtani AS, et al. Assessment of the Anticancer Effect of Chlorojanerin Isolated from Centaurothamnus maximus on A549 Lung Cancer Cells. Molecules. 2023. doi:10.3390/molecules28073061
BibTeX
@article{Noman2023,
author = {Noman, Omar and Nasr, Fahd A and Ahmed, Mohammad Z and Rehman, Md Tabish and Qamar, Wajhul and Alqahtani, Ali S and Guenther, Sebastian},
title = {Assessment of the Anticancer Effect of Chlorojanerin Isolated from Centaurothamnus maximus on A549 Lung Cancer Cells},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28073061}
}
EUVIMED